Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Econo-gloom bypasses pharma earnings
Fierce Pharma
Monday, October 12, 2009 - 9:53am
tags:
earnings, JNJ, Abbott Laboratories, Roche
Why I'm Taking a Foothold in Generex Now
Seeking Alpha
Monday, October 12, 2009 - 9:20am
tags:
Generex, MannKind, Invo Bioscience, NovaDel
DepoMed Trial Disappoints; Shares Plunge
TheStreet.com
Monday, October 12, 2009 - 9:19am
tags:
Depomed, drug trials, Serada, hot flashes, menopause
Santarus licenses GI-disorder drug to Norgine
Marketwatch
Monday, October 12, 2009 - 9:18am
tags:
Norgine, Santarus
Pfizer's Silence on Post-Wyeth Merger Job Cuts, Site Closures Has Everyone on Edge
BNET Pharma
Monday, October 12, 2009 - 9:17am
tags:
Pfizer, Wyeth, M&A, reorganization
Johnson & Johnson makes 4 deals, awaits new product approvals amid slumping sales
Yahoo/AP
Monday, October 12, 2009 - 9:15am
tags:
JNJ, Gilead Sciences, Merck
Health Workers Sue to Void FDA Approval of Swine Flu Vaccine
Bloomberg
Monday, October 12, 2009 - 9:12am
tags:
swine flu, vaccines, H1N1, FDA
Onyx to Buy Proteolix for $276 Million, Gaining a Cancer Drug
Bloomberg
Monday, October 12, 2009 - 9:09am
tags:
cancer, Proteolix, ONYX Pharmaceuticals, M&A
Pfizer Suspends Lung Cancer Study
Forbes
Monday, October 12, 2009 - 9:08am
tags:
Pfizer, lung cancer, figitumumab
Merial invests US $70 million in Nanchang, China
Yahoo
Monday, October 12, 2009 - 9:04am
tags:
Merial, China, animal health
Lupin eyes $200 mn opportunity in US mkt
Indian Express
Sunday, October 11, 2009 - 11:39am
tags:
Lupin
Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug
Medical News Today
Sunday, October 11, 2009 - 11:37am
tags:
Pfizer, AIDS, Selzentry
Glaxo Expands Presence in China
Yahoo/Zacks
Saturday, October 10, 2009 - 12:39pm
tags:
GSK, China
Savient Pharma recovers after analyst upgrade
Yahoo/AP
Saturday, October 10, 2009 - 12:38pm
tags:
Savient, Krystexxa, gout
Avanir, Acorda move on MS drug updates
Market Watch
Saturday, October 10, 2009 - 12:37pm
tags:
Avanir, Acorda Therapeutics, MS
Dendreon to Seek FDA Approval
Yahoo/Zacks
Saturday, October 10, 2009 - 12:36pm
tags:
Dendreon, Provenge
ADVENTRX Pharmaceuticals Announces Closing of Financing
Yahoo/PR NewsWire
Saturday, October 10, 2009 - 12:35pm
tags:
Adventrx
Hemispherx CEO Carter Speaks: BioBuzz
The Street
Saturday, October 10, 2009 - 12:33pm
tags:
Hemispherx, Ampligen
Facet Investors Urged to Deny Offer
Yahoo/Zacks
Saturday, October 10, 2009 - 12:32pm
tags:
Facet Biotech, Biogen Idec
Plexxikon Treats Initial Patient with First-in-Class Drug in Phase 1 Trial
Pipeline Review
Saturday, October 10, 2009 - 12:05pm
tags:
Plexxikon, cancer, rheumatoid arthritis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.